Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Insulet Corporation (PODD) To Contact The Firm
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at Insulet Corporation (“Insulet” or the “Company”) (Nasdaq: PODD).
The investigation focuses on whether the Company and its executives violated federal securities laws by failing to disclose that: (1) the Company was experiencing weakening demand for its OmniPod Insulin Management System products; (2) Insulet was facing problems with its sales and marketing efforts; and (3) that, as a result, the Company was experiencing poor financial performance.
On April 30, 2015, Insulet announced first quarter 2015 earnings well below analyst expectations. According to the Company, certain Drug Delivery and International shipments planned for the first quarter of 2015 were expected to be realized later in 2015.
On this unexpected news, shares of Insulet declined $2.88 per share, nearly 10%, to close on May 1, 2015, at $26.97 per share, on unusually heavy volume.
If you invested in Insulet stock or options between February 27, 2013 and April 30, 2015 and would like to discuss your legal rights, you can contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to firstname.lastname@example.org. Faruqi & Faruqi, LLP also encourages anyone with information regarding Insulet’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
Richard W. Gonnello
Faruqi & Faruqi, LLP
685 Third Avenue 26th Floor
New York, NY 10017
Tel: (212) 983-9330
If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.